Ubs Asset Management Americas Inc Exact Sciences Corp Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,909,413 shares of EXAS stock, worth $103 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,909,413
Previous 3,128,958
38.98%
Holding current value
$103 Million
Previous $135 Million
25.09%
% of portfolio
0.02%
Previous 0.04%
Shares
31 transactions
Others Institutions Holding EXAS
# of Institutions
651Shares Held
157MCall Options Held
1.43MPut Options Held
2.3M-
Capital World Investors Los Angeles, CA18.2MShares$981 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$965 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$650 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$647 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$290 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.54B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...